Drug recall · January 6, 2021
Neostigmine Methylsulfate PF Inj. 5 mg/5 mL recall
Why: Labelling: Missing label.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270 Don's Lane Conway, AR 72032 (800) 718-3588 NDC 62295-3324-05
- Lots / codes
Lot: 20202109@3 BUD: 3/20/2021
- Quantity
- 1640 syringes
- Company
- US Compounding Inc, Conway, AR
- Distribution
- Nationwide
- Initiated
- November 25, 2020 · Voluntary: Firm initiated
- Classified
- December 29, 2020
- Reported
- January 6, 2021
- Ended
- November 5, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Neostigmine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.